Blastomycosis in Africa and the Middle East: A Comprehensive Review of Reported Cases and Reanalysis of Historical Isolates Based on Molecular Data

ABSTRACT: Background: Blastomycosis has been reported from countries in Africa and the Middle East, but a decades-long debate has persisted regarding whether this is the same disease known in North America and caused by Blastomyces dermatitidis and Blastomyces gilchristii. Methods: We reviewed publi...

Full description

Autores:
McEwen Ochoa, Juan Guillermo
Muñoz Gómez, José Fernando
Kenyon, Chris
Govender, Nelesh P.
McTaggart, Lisa
Maphanga, Tsidiso G.
Richardson, Susan
Becker, Pierre
Cuomo, Christina A.
Sigler, Lynne
Schwartz, Ilan S.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/44761
Acceso en línea:
https://hdl.handle.net/10495/44761
Palabra clave:
Blastomicosis
Blastomycosis
Blastomyces
Medio Oriente
Middle East
Sudáfrica
South Africa
Enfermedades Desatendidas
Neglected Diseases
Enfermedades de la Piel
Skin Diseases
https://id.nlm.nih.gov/mesh/D001758
https://id.nlm.nih.gov/mesh/D001759
https://id.nlm.nih.gov/mesh/D008877
https://id.nlm.nih.gov/mesh/D013019
https://id.nlm.nih.gov/mesh/D058069
https://id.nlm.nih.gov/mesh/D012871
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Summary:ABSTRACT: Background: Blastomycosis has been reported from countries in Africa and the Middle East, but a decades-long debate has persisted regarding whether this is the same disease known in North America and caused by Blastomyces dermatitidis and Blastomyces gilchristii. Methods: We reviewed published cases of human and veterinary blastomycosis from Africa and the Middle East. We abstracted epidemiological and clinical features of cases, including sites of disease, diagnosis, management, outcomes, and, where available, genetic and antigenic typing of case isolates. In addition, we sequenced nucleic acids from 9 clinical isolates from Africa deposited in global collections as B. dermatitidis; for 5, we sequenced the internal transcribed spacer regions, and for the other 4 we sequenced the whole genomes. Results: We identified 172 unique human patients with blastomycosis, including 159 patients from 25 African countries and 12 patients from 5 Middle Eastern countries, and also identified 7 reports of veterinary blastomycosis. In humans, cutaneous disease predominated (n = 100/137, 73%), followed by pulmonary (n = 73/129, 57%) and osteoarticular involvement (n = 61/128, 48%). Unusual direct microscopy/histopathological presentations included short hyphal fragments in tissues (n = 23/129, 18%). There were 34 genotyped case isolates that comprised 4 species: Blastomyces percursus (n = 22, 65%), from 8 countries throughout all regions; Blastomyces emzantsi (n = 9, 26%), from South Africa; B. dermatitidis (n = 1, 3%), from the Democratic Republic of Congo; and B. gilchristii (n = 2, 6%), from South Africa and Zimbabwe. Conclusions: Blastomycosis occurs throughout Africa and the Middle East and is caused predominantly by B. percursus and, at least in South Africa, B. emzantsi, resulting in distinct clinical and pathological patterns of disease.